Search
Now showing items 1-7 of 7
Willingness to participate in genome testing: a survey of public attitudes from Qatar
(
Springer
, 2020 , Article)
Genomics has the potential to revolutionize medical approaches to disease prevention, diagnosis, and treatment, but it does not come without challenges. The success of a national population-based genome program, like the ...
The Reproductive Agency Scale (RAS-17): Development and validation in a cross-sectional study of pregnant Qatari and non-Qatari Arab Women
(
BMC
, 2020 , Article)
© 2020 The Author(s). Background: Sustainable Development Goal (SDG) 5 prioritizes women's empowerment and gender equality, alone and as drivers of other SDGs. Efforts to validate universal measures of women's empowerment ...
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.
(
Oxford University Press
, 2021 , Article)
Qatar experienced a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic that disproportionately affected the craft and manual worker (CMW) population, who comprise 60% of the total population. This study ...
Prevalence, Risk Factors, Harm Perception, and Attitudes Toward E-cigarette Use Among University Students in Qatar: A Cross-Sectional Study.
(
Frontiers Media
, 2021 , Article)
Electronic cigarette (e-cigarette) use is becoming more popular worldwide, especially among youth. Studies report that university students have inadequate knowledge as well as misconceptions about the health risks of ...
Harm Perception and Attitudes towards E-cigarette Use Among Qatar University Students: A Cross-Sectional Study
(
Qatar University Press
, 2021 , Poster)
Background: Electronic cigarette (e-cigarette) use is becoming popular worldwide especially among youth. Research reported that university students have poor knowledge and misconceptions about the health risks of e-cigarettes, ...
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
(
Massachusetts Medical Society
, 2022 , Article)
The BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) has been authorized for use in children 5 to 11 years of age and adolescents 12 to 17 years of age but in different antigen doses. We assessed the real-world ...
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
(
Elsevier
, 2022 , Article)
BackgroundUnderstanding protection conferred by natural SARS-CoV-2 infection versus COVID-19 vaccination is important for informing vaccine mandate decisions. We compared protection conferred by natural infection versus ...